- Home
- VRA vs ACHV Comparison
VRA vs ACHV Comparison
Compare VRA & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- ACHV
- Stock Information
- Founded
- VRA 1982
- ACHV N/A
- Country
- VRA United States
- ACHV Canada
- Employees
- VRA N/A
- ACHV N/A
- Industry
- VRA Apparel
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VRA Consumer Discretionary
- ACHV Health Care
- Exchange
- VRA Nasdaq
- ACHV Nasdaq
- Market Cap
- VRA 162.4M
- ACHV 159.0M
- IPO Year
- VRA 2010
- ACHV N/A
- Fundamental
- Price
- VRA $4.96
- ACHV $4.52
- Analyst Decision
- VRA Strong Buy
- ACHV Strong Buy
- Analyst Count
- VRA 1
- ACHV 3
- Target Price
- VRA $10.00
- ACHV $14.00
- AVG Volume (30 Days)
- VRA 606.9K
- ACHV 85.7K
- Earning Date
- VRA 09-11-2024
- ACHV 11-07-2024
- Dividend Yield
- VRA N/A
- ACHV N/A
- EPS Growth
- VRA N/A
- ACHV N/A
- EPS
- VRA 0.02
- ACHV N/A
- Revenue
- VRA $439,677,000.00
- ACHV N/A
- Revenue This Year
- VRA $0.38
- ACHV N/A
- Revenue Next Year
- VRA $6.24
- ACHV N/A
- P/E Ratio
- VRA $194.53
- ACHV N/A
- Revenue Growth
- VRA N/A
- ACHV N/A
- 52 Week Low
- VRA $4.38
- ACHV $3.03
- 52 Week High
- VRA $8.35
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- VRA 34.24
- ACHV 50.71
- Support Level
- VRA $4.38
- ACHV $4.23
- Resistance Level
- VRA $5.89
- ACHV $4.33
- Average True Range (ATR)
- VRA 0.24
- ACHV 0.15
- MACD
- VRA -0.06
- ACHV 0.02
- Stochastic Oscillator
- VRA 38.79
- ACHV 53.13
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.